In the era of DOACs, risk for CTEPH following pulmonary embolism is affected by multiple factors, including gender and heart load.

Increasing average concentrations of sotatercept improved 6-minute walk distance, pulmonary vascular resistance, and levels of NT-proBNP.

After the FDA approved both combination macitentan/tadalafil (Opsynvi) and the biologic therapy sotatercept (Winrevair) for ...

Renal denervation (RDN) is recognized as an adjunct therapy for hypertension management with a favorable and consistent blood pressure–lowering efficacy and safety profile. Alteration in medication ...

Stroke affects nearly 800,000 Americans each year. It is the fifth leading cause of death in the United States. A basilar artery stroke occurs when blood flow to the brain is interrupted. This can ...

The role of echocardiography in acute pulmonary embolism (PE) remains incompletely defined. Echocardiography cannot reliably diagnose acute PE, and it does not improve prognostication of patients with ...

Cleerly’s FDA-cleared AI takes CT scans of the heart and analyzes the findings for signs of coronary artery disease. The former Fierce 15 winner’s programs aim to spot plaque buildups inside ...

The pulmonary valve connects the right ventricle to the pulmonary artery. It normally has 3 flaps (leaflets) that work like a 1-way door. This means they allow blood to flow from the right ventricle ...

PA is a problem with the opening of the pulmonary valve. This valve connects the right ventricle and the main pulmonary artery. This artery carries blood to the lungs. With PA, blood can’t flow to the ...